Abstract
Nimesulide is an anti-inflammatory drug (NSAID) whose preferential selectivity for cyclooxygenase-2 (COX-2) leads to fewer adverse effects. Nimesulide acts on a single metabolic pathway of the arachidonic acid cascade. Recent studies show that multi-target NSAID is an important strategy for obtaining drugs fewer adverse effects. LQFM-091 has been proposed as a molecular hybridization from nimesulide and BF-389, with the aim to inhibit two enzymes involved in arachidonic acid metabolic cascade. The aim this work was the electrochemical characterization of LQFM-091. The electrochemical analyzes were conclusive to prove that the electroactive groups are unhindered and were important in this drug action mechanism.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
